The notices it replaced
2 notices since 2019, oldest first, each with its awards since FY2014.
- Posted 2019RFA-HL-20-0066 awards
- Posted 2022RFA-HL-23-00715 awards
- Posted 2026RFA-HL-27-010This notice, open
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 21
- 21 new
- Median first-year cost
- $107,752
- $2,162,444 in all
- Institutions
- 10
- 21 contact PIs
Awards by fiscal year
0
0
0
0
0
0
2
2
2
3
7
5
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO6
- DUKE UNIVERSITY5
- EMORY UNIVERSITY2
- UNIVERSITY OF CALIFORNIA LOS ANGELES2
- BETH ISRAEL DEACONESS MEDICAL CENTER1
and 5 other institutions
Most frequent study sections
- Special Emphasis Panel (ZHL1 CSR-I (M1))8
- Special Emphasis Panel (ZHL1 CSR-I (M3))4
- Transition to Independence Study Section (I) (NCI-I)3
- Special Emphasis Panel (ZHL1 CSR-S (M1))2
- Special Emphasis Panel (ZHL1 CSR-Z (M2))2
and 2 other study sections
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2025 | The Role of Rheology and Transfusion on Microvascular Thrombosis in Sepsis1K38HL181374-01 · under RFA-HL-23-007 | Iffrig, Elizabeth M | EMORY UNIVERSITY, GA | First-year cost $110,635 | Study section ZHL1 |
| FY2025 | Epithelial cell mediated fibroblast activation through CTHRC1-TGFb signaling in fibrotic lung diseases1K38HL180998-01 · under RFA-HL-23-007 | Khatri, Aaditya | DUKE UNIVERSITY, NC | First-year cost $107,752 | Study section ZHL1 |
| FY2025 | Improving integration of treatment burden information in primary care for older adults with multiple chronic conditions1K38AG094915-01 · under RFA-HL-23-007 | Zhang, Audrey Dee | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | First-year cost $107,330 | Study section ZHL1 |
| FY2025 | The Role of Developmental Dysanapsis in Lung Development Throughout the Lifespan in Experimental Bronchopulmonary Dysplasia1K38HL180910-01 · under RFA-HL-23-007 | McGinn, Elizabeth | UNIVERSITY OF COLORADO DENVER, CO | First-year cost $106,391 | Study section ZHL1 |
| FY2025 | Predictive Markers of Response to and Treatment Effects of Motixafortide, Cemiplimab, Gemcitabine and Nab-Paclitaxel in Treatment Naïve Metastatic Pancreatic Cancer1K38CA304069-01 · under RFA-HL-23-007 | May, Michael Stevenson | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $1 | Study section NCI |
| FY2024 | Control of adipose immune-stromal niche topography in obesity1K38HL175025-01 · under RFA-HL-23-007 | Balcerek, Joanna | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $115,949 | Study section ZHL1 |
| FY2024 | The Lipofibroblast to Myofibroblast Transition in Systemic Sclerosis1K38HL175027-01 · under RFA-HL-23-007 | Young, Arissa C | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | First-year cost $110,959 | Study section ZHL1 |
| FY2024 | Age-Related Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Exercise Responsiveness1K38HL175026-01 · under RFA-HL-23-007 | Regan, Jessica Ann | DUKE UNIVERSITY, NC | First-year cost $104,933 | Study section ZHL1 |
| FY2024 | B Cell-Fibroblast Crosstalk Promotes Chronic GVHD of the Lung1K38AI185078-01 · under RFA-HL-23-007 | Bracken, Sonali Jagdish | DUKE UNIVERSITY, NC | First-year cost $104,435 | Study section AITC |
| FY2024 | Metabolic regulation of oxidative phosphorylation in pediatric AML relapse1K38CA282963-01A1 · under RFA-HL-23-007 | Zachman, Derek | DUKE UNIVERSITY, NC | First-year cost $103,853 | Study section NCI |
| FY2024 | Cell-Free DNA Methylation Patterns as a Biomarker for Tumor Biology and Clinical Outcomes for Glioblastoma Patients1K38CA292995-01 · under RFA-HL-23-007 | Vaios, Eugene | DUKE UNIVERSITY, NC | First-year cost $100,586 | Study section NCI |
| FY2024 | The impact of diet on granulopoiesis, neutrophil function, and sickle cell disease pathology1K38HL174893-01 · under RFA-HL-23-007 | Mack, Ethan Andrew | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $89,640 | Study section ZHL1 |
| FY2023 | Investigating the Genotype-Phenotype Relationships that Underlie Congenital Disorders with Cardiovascular Symptoms through Population-scale Analyses1K38HL164956-01A1 · under RFA-HL-23-007 | Blair, David Randall | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $109,752 | Study section ZHL1 |
| FY2023 | Improving the Identification of Opioid-Associated Out-of-Hospital Cardiac Arrest1K38HL165363-01A1 · under RFA-HL-23-007 | Dillon, David G | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | First-year cost $106,164 | Study section ZHL1 |
| FY2023 | Identifying genetic drivers of circulating metabolites associated with cardiac risk in pediatric chronic kidney disease1K38HL169660-01 · under RFA-HL-23-007 | Lee, Arthur | CHILDREN'S HOSP OF PHILADELPHIA, PA | First-year cost $105,867 | Study section ZHL1 |
| FY2022 | Using Machine Learning and Patient-Reported Outcomes to Identify Unnecessary Hospitalizations1K38HL164955-01 · under RFA-HL-20-006 | Leuchter, Richard K | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | First-year cost $111,866 | Study section ZHL1 |
| FY2022 | Control of ribosomal function in cells of the hematopoietic system1K38HL165490-01 · under RFA-HL-20-006 | Levine, Andrew | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $111,089 | Study section ZHL1 |
| FY2021 | Deep learning tools for the automated analysis of hematopathology whole slide images and the development of prognostic algorithms for hematopoietic stem cell transplant recipients1K38HL159128-01 · under RFA-HL-20-006 | Goldgof, Gregory Mark | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $119,318 | Study section ZHL1 |
| FY2021 | Systems Biology Approach to SARS-CoV-2 Infection in Individuals with known COVID-19 Contacts: A Prospective Cohort Study1K38AI163480-01 · under RFA-HL-20-006 | Scanlon, Nicholas | EMORY UNIVERSITY, GA | First-year cost $108,886 | Study section ZAI1 |
| FY2020 | Host-parasite lipid metabolism in Trypanosoma cruzi-infected cardiac myocytes1K38HL154203-01 · under RFA-HL-20-006 | Whitman, Jeffrey Dominick | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $113,519 | Study section ZHL1 |
| FY2020 | The Role of PPARgamma in Th2 cells and Obesity-Associated Asthma.1K38HL154202-01 · under RFA-HL-20-006 | Bapat, Sagar Pradeep | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $113,519 | Study section ZHL1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.